Brendan Smith
Stock Analyst at TD Cowen
(0)
# 4621
Out of 5,358 analysts
8
Total ratings
33.33%
Success rate
-14.97%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DNA Ginkgo Bioworks Hold... | Maintains: Strong Buy | 3 10 | 7.57 | 32.1% | 1 | Sep 20, 2024 | |
EXAI Exscientia | Downgrades: Hold | n/a | n/a | n/a | 2 | Aug 9, 2024 | |
HALO Halozyme Therapeutic... | Maintains: Strong Buy | 59 65 | 54.25 | 19.82% | 2 | Aug 7, 2024 | |
NVAX Novavax | Maintains: Hold | 5 10 | 7.45 | 34.23% | 1 | May 13, 2024 | |
ARWR Arrowhead Pharma | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Dec 5, 2022 |